Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,446,045 Methods of using selective chemotherapeutic agents for targeting tumor cells
A method for treating cancer tumors, particularly ovarian cancer tumors, is described, where fused cyclic pyrimidine having a cancer treating ability is...
US-9,446,044 DYRK1 inhibitors and uses thereof
The present invention relates to novel thiazolo[5,4-f]quinazoline compounds and methods that are useful in the amelioration, treatment or control of Down's...
US-9,446,043 Pharmaceutical combinations
A pharmaceutical combination comprising (a) a protein kinase C (PKC) inhibitor compound, or a pharmaceutically acceptable salt thereof, and (b) at least one...
US-9,446,042 Pro-neurogenic compounds
This invention relates generally to stimulating neurogenesis (e.g., post-natal neurogenesis, e.g., post-natal hippocampal neurogenesis) and protecting from...
US-9,446,041 Method of treatment
The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises...
US-9,446,040 Substituted imidazoquinolines
Imidazoquinolines of formula I that contain substituted amine or amide functionality at 1-position and that are effective as Toll like Receptor 7 activators are...
US-9,446,039 Aminoheteroaryl compounds as MTH1 inhibitors
The present invention relates to an (S)-enantiomer of an aminoheteroaryl compound for use in treating and/or preventing cancer in a subject. The invention...
US-9,446,038 Method and composition for treating a serotonin receptor-mediated condition
A method and composition for treating serotonin receptor-mediated conditions.
US-9,446,037 Methods for the treatment of parkinson's disease psychosis using pimavanserin
Methods for the treatment of Parkinson's disease psychosis which comprise the administration of pimavanserin.
US-9,446,036 Compositions of a polyorthoester and an aprotic solvent
Delivery systems and compositions comprised of a biodegradable polyorthoester polymer, an aprotic solvent, and a drug are described. The solvent is selected to...
US-9,446,035 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
Provided herein are compounds according to Formula I and pharmaceutically acceptable salts thereof, and compositions comprising the same, for use in various...
US-9,446,034 Pyrazolylaminopyridines as inhibitors of FAK
The present invention relates to a compound of formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof, wherein R.sup.1, R.sup.2, R.sup.3,...
US-9,446,033 Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to injury
The purpose of the present invention is to identify a migratory factor that guides pluripotent stem cells (Muse cells) useful in new medical applications to...
US-9,446,032 Methods for treating cardiovascular disorders
There is provided a once-a-day therapeutically synergistic pharmaceutical dosage form for treatment of cardiovascular disorders, wherein the dosage form...
US-9,446,031 Compositions and methods for neovascularization
The invention is directed to a method of inducing angiogenesis at a site in an individual in need thereof comprising administering locally to the site an...
US-9,446,030 Methods and pharmaceutical compositions for the treatment of symptoms of anxiety and panic using beta...
The present invention is focused primarily toward pro re nata ("as needed") treatments for a psychiatric condition or disorder or the symptoms thereof,...
US-9,446,029 Use of NK-1 receptor antagonists in management of visceral pain
Methods for managing visceral pain in mammalian subjects are described, in which a NK-1 receptor antagonist is administered to the subject before, during or...
US-9,446,028 Methods of increasing tonic inhibition and treating fragile X syndrome and angelman syndrome
Methods of increasing tonic inhibition in a subject in need thereof, for example a subject with Fragile X syndrome or Angelman syndrome are disclosed. Methods...
US-9,446,027 Use of pidotimod to treat irritable bowel syndrome
The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of...
US-9,446,026 Ocular formulations for drug-delivery to the posterior segment of the eye
The present invention relates to topical formulations comprising a compound of the following formula: ##STR00001## for treating ocular neovascularization. The...
US-9,446,025 Treatment or prevention of hypotension and shock
The present invention relates to a method for the prevention and treatment of hypotension and shock due to low peripheral resistance, comprising administering...
US-9,446,024 Formulations for the treatment of vaginal disorders
The present disclosure provides novel formulations suitable for the intravaginal delivery of tinidazole, as well as methods of using the same.
US-9,446,023 Methods and compositions involving (S)-bucindolol
Disclosed is bucindolol substantially free of its R-stereoisomer. Also disclosed are pharmaceutical compositions that include bucindolol substantially free of...
US-9,446,022 Pro-neurogenic compounds
This technology relates generally to compounds and methods for stimulating neurogenesis (e.g., post-natal neurogenesis, including post-natal hippocampal and...
US-9,446,021 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures,...
US-9,446,020 Methods for Alzheimer'S disease treatment and cognitive enhancement
The present invention relates to compositions and methods to modulate .alpha.-secretase and/or to improve cognitive ability. The invention further relates the...
US-9,446,019 Sparstolonin B based pharmaceutical agent for neuroblastoma treatment
Use of sparstolonin B in inhibition of growth and/or viability of human neuroblastoma cells is described. The sparstolonin B can be naturally derived from the...
US-9,446,018 Pharmaceutical composition for treating or preventing angina or myocardial infarction induced by myocardial...
The present invention provides a pharmaceutical composition for the treatment and prophylaxis of angina and myocardial infarction, wherein a combination of a...
US-9,446,017 Compositions and methods for treating herpes simplex virus
Green tea polyphenol compositions and methods of their use in treating herpes simplex virus (HSV) are provided. Representative green tea polyphenols include,...
US-9,446,016 Methods of treating age related disorders
The invention generally relates to methods of treating a patient having, and/or at risk of, oxidative distress disorders and/or age-related disorders. The...
US-9,446,015 Quinone based nitric oxide donating compounds for ophthalmic use
The present invention relates to novel nitric oxide donor compounds for the use in the treatment and/or prophylaxis of hypertensive glaucoma, normotensive...
US-9,446,014 Composition for improving membrane composition and functioning of cells
It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical...
US-9,446,013 Method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of ...
Embodiments of the invention comprise methods of reducing circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 and circulating Myeloperoxidase...
US-9,446,012 Pharmaceutical compounds
This invention relates to novel substituted nitrocatechol derivatives, their use in the treatment of some central and peripheral nervous system disorders and...
US-9,446,011 Anticonvulsant combination therapy
The present invention is directed to a pharmaceutical composition comprising a Compound (a) of a class of peptide Compounds and at least one further Compound...
US-9,446,010 Compounds and methods for treating aberrant adrenocortical cell disorders
Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment...
US-9,446,009 Methods for treating conditions of the nail unit
The biodegradable drug delivery systems described here are formulated for implantation into the nail unit and its surrounding tissues for the treatment of...
US-9,446,008 Semisolid aqueous pharmaceutical composition containing tapentadol
A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof.
US-9,446,007 Methods for maintaining or improving health, well-being and/or a physiological function in a subject
The invention relates to a method of treating or preventing a condition in a subject, comprising administering to the subject an acceptable composition...
US-9,446,006 Hydroxytyrosol combinations for enhancing mitochondrial function and energy production
Hydroxytyrosol or olive juice containing hydroxytyrosol in combination with at least one of the compounds selected from the group consisting of: creatine,...
US-9,446,005 Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving...
US-9,446,004 Transdermal nicotine salt delivery system
A transdermal nicotine salt delivery system to an individual. The system has a high nicotine salt loading to effect therapeutic flux rate. Acrylate polymeric...
US-9,446,003 Prion free nanoparticle compositions and methods of making thereof
The present invention provides prion-free compositions comprising nanoparticles comprising albumin and substantially water insoluble drugs. Also provided are...
US-9,446,002 Spheroids and multiparticulate tablets comprising them
The invention relates to a directly-compressible gastro-resistant spheroid. The spheroid comprises: (i) a core containing one or more active substances; (ii) a...
US-9,446,001 Increasing drug affinity for crystalline microparticle surfaces
Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to...
US-9,446,000 Cellulosic gel material as a pharmaceutical excipient
A method of making a pharmaceutical tablet comprises (a) combining (i) an aqueous networked cellulose gel with (ii) filler and (iii) an active agent to form a...
US-9,445,999 Process for preparing carrier particles for dry powders for inhalation
Carrier particles in which at least 60% of the surface is coated with magnesium stearate are useful for preparing dry powder formulations for inhalation.
US-9,445,998 Pharmaceutical dosage forms comprising a low-solubility drug and a polymer
A dosage form comprises a low-solubility drug, and a precipitation-inhibiting polymer. The drug is in a solubility-improved form and in the form of particles at...
US-9,445,997 Microcapsules comprising a fat-soluble active substance
The invention relates to microcapsule comprising at least one fat-soluble active substance selected from provitamins, vitamins and esters thereof, ...
US-9,445,996 Extended production of nitric oxide from a microencapsulated nitrite salt and an aqueous acidified gel
Methods and compositions are provided for generating and applying long-lasting therapeutic nitric oxide (NO) gas from the reaction of a least one...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.